Ten Capital Wealth Advisors’s AbbVie ABBV Stock Holding History

Ten Capital Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$362K	Buy	2,693 +473	+21%	+$69.4K	0.11%	79
2023 Q1	$354K	Buy	2,220 +175	+9%	+$26.8K	0.12%	60
2022 Q4	$330K	Buy	2,045 +723	+55%	+$111K	0.13%	55
2022 Q3	$177K	Buy	1,322 +188	+17%	+$27K	0.08%	83
2022 Q2	$174K	Sell	1,134 -2,726	-71%	-$417K	0.08%	82
2022 Q1	$626K	Hold	3,860	–	–	0.26%	40
2021 Q4	$523K	Hold	3,860	–	–	0.21%	40
2021 Q3	$416K	Buy	3,860 +525	+16%	+$60K	0.19%	42
2021 Q2	$376K	Hold	3,335	–	–	0.09%	104
2021 Q1	$360K	Hold	3,335	–	–	0.09%	107
2020 Q4	$357K	Hold	3,335	–	–	0.1%	101
2020 Q3	$292K	Buy	+3,335	New	+$314K	0.1%	92

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ten Capital Wealth Advisors's ABBV Position: Q2 2023 in Review

Ten Capital Wealth Advisors increased its AbbVie (ABBV) stake by 21% in Q2 2023, buying an estimated $69.4K and bringing the position to 2,693 shares worth $362K. The position accounts for 0.11% of the portfolio, ranked #79.

Ten Capital Wealth Advisors first reported a position in ABBV in Q3 2020 and has held it in 12 quarters since. The position peaked at $626K in Q1 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Ten Capital Wealth Advisors held 2,693 shares of AbbVie worth $362K as of Q2 2023.
Ten Capital Wealth Advisors bought 473 AbbVie shares in Q2 2023, an estimated $69.4K.
AbbVie made up 0.11% of Ten Capital Wealth Advisors's portfolio in Q2 2023, its #79 holding.
Ten Capital Wealth Advisors first reported a position in AbbVie in Q3 2020 and has held it in 12 quarters since.
Ten Capital Wealth Advisors's AbbVie position peaked at $626K in Q1 2022.
3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.